Sexual and Urinary Function Improvement for Cancer Survivors

Sexual and Urinary Function Improvement for Cancer Survivors- Promoting Access to Collaborative Treatment (SUFICS-PACT)

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06637852

Enrollment

200

Registered

2024-10-15

Start date

2026-10-01

Completion date

2030-03-31

Last updated

2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction, Urinary Dysfunction

Brief summary

The purpose of this study is to test the efficacy of SUFICS-PACT to identify and treat sexual and urinary dysfunction in prostate cancer survivors at NYC H+ H/Bellevue, the oldest public hospital in the US. This study will evaluate the implementation of an adapted sexual and urinary function collaborative care model at NYC Health+Hospitals/Bellevue. The study will test the efficacy of this collaborative care model through a randomized controlled trial in the adult primary care clinic; the intervention arm will receive collaborative treatment consisting of a care manager who has specialty training in mental health and psychosexual counseling, a primary care nurse practitioner who leads symptom management, primary care physicians who supervise the team, and a team specialty consult liaison.

Interventions

BEHAVIORALSUFICS-PACT

SUFICS-PACT includes sexual and urinary dysfunction screening, collaborative treatment of sexual and urinary dysfunction, and care managers who are mental health professionals with training in psychosexual counseling. Mental health professionals will facilitate a comprehensive approach to sexual dysfunction, as emphasized by the biopsychosocial model of sexual health. SUFICS-PACT also emphasizes close follow up, which is important for sexual function recovery after prostate cancer treatment.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* At least 18 years old * Have a diagnosis of prostate cancer * Have sought care/treatment for prostate cancer

Exclusion criteria

* Patients under 18 years old * Patients who have not sought care/treatment for prostate cancer * Patients who are categorized as "vulnerable subjects," such as minors or incarcerated individuals.

Design outcomes

Primary

Measure	Time frame
Number of patients identified and treated for sexual dysfunction	Year 5
Number of patients identified and treated for urinary dysfunction	Year 5

Countries

United States

Contacts

CONTACTNnenaya Mmonu, MD, MS

Nnenaya.Mmonu@nyulangone.org646-825-6300

CONTACTFavour Nnah

Favour.Nnah@nyulangone.org917-854-5895

PRINCIPAL_INVESTIGATORNnenaya A. Mmonu, MD, MS

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026